JoelRobertPekowMD

Gastroenterology • Chicago, IL

Associate Professor, Medicine, University of Chicago Div of the Bio Sci The Pritzker SOM

Join to view full profile

Dr. Pekow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pekow's full profile

Already have an account?

Office
5841 S Maryland Ave
Chicago, IL 60637
Phone+1 888-824-0200

Fax+1 773-702-2182

Education & Training

University of ChicagoFellowship, Gastroenterology, 2007 - 2010
Massachusetts General HospitalResidency, Internal Medicine, 2003 - 2006
University of Illinois College of MedicineClass of 2003

Certifications & Licensure

IL State Medical License 2006 - 2026
MA State Medical License 2005 - 2007
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis Start of enrollment: 2013 Nov 01
Terminated
Phase 2

Publications & Presentations

PubMed

47 citations
Wnt-β-catenin activation epigenetically reprograms Treg cells in inflammatory bowel disease and dysplastic progression.
Jasmin Quandt, Stephen Arnovitz, Leila Haghi, Janine Woehlk, Azam Mohsin
Nature Immunology. 2021-03-04
100 citations
Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry
Colleen R. Kelly, Eugene F. Yen, Ari Grinspan, Stacy A. Kahn, Ashish Atreja
Gastroenterology. 2021-01-01
29 citations
Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases
Anthony Buisson, Wing Yan Mak, Michael J. Andersen, Donald Lei, Stacy A. Kahn
Journal of Crohn's & Colitis. 2018-01-16

Journal Articles

Correction to: Risk Factors for Clostridium Difficile Isolation in Inflammatory Bowel Disease: A Prospective Study
Sushila Dalal, Vijaya L Rao, Laura R Glick, Russell Cohen, Ayal Hirsch, Dejan Micic, Joel Pekow, Atsushi Sakuraba, David T Rubin, Digestive Diseases and Sciences

Authored Content

Effectiveness of Ustekinumab Dose Escalation in Crohn's PatientsFebruary 2020

Press Mentions

Fecal Transplant with Anti-Inflammatory Diet Yields Remissions in UCAugust 18th, 2022
Fecal Transplant with Anti-Inflammatory Diet Produces Remissions in UC -News ForestAugust 18th, 2022
The Pros and Cons of Biologics for Ulcerative ColitisJuly 2nd, 2024